+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Covid 19 Clinical Trial"

From
From
GCC Clinical Trial Market Outlook 2025 - Product Thumbnail Image

GCC Clinical Trial Market Outlook 2025

  • Report
  • August 2020
  • 330 Pages
  • Middle East
From
Global Coronavirus COVID 19 Clinical Trials Insight 2020 - Product Thumbnail Image

Global Coronavirus COVID 19 Clinical Trials Insight 2020

  • Report
  • March 2020
  • 60 Pages
  • Global
From
From
From
Clinical Trials - Impact of COVID-19 and Long COVID - Product Thumbnail Image

Clinical Trials - Impact of COVID-19 and Long COVID

  • Report
  • May 2023
  • 60 Pages
  • Global
From
From
From
Coronavirus Disease 2019 (COVID-19) - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Coronavirus Disease 2019 (COVID-19) - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • September 2021
  • 2992 Pages
  • Global
From
From
From
Antiviral Therapeutics - Technologies, Markets & Companies - Product Thumbnail Image

Antiviral Therapeutics - Technologies, Markets & Companies

  • Report
  • November 2021
  • 620 Pages
  • Global
From
  • 15 Results (Page 1 of 1)
Loading Indicator

The Covid 19 Clinical Trial market is a subset of the Infectious Diseases Drugs market. It is focused on the development of treatments and vaccines for the novel coronavirus. Clinical trials are conducted to evaluate the safety and efficacy of potential treatments and vaccines. These trials are conducted in phases, with each phase providing increasingly detailed information about the drug or vaccine. The results of these trials are used to determine whether the drug or vaccine should be approved for use in humans. The Covid 19 Clinical Trial market is highly competitive, with many companies vying for a share of the market. Companies such as Pfizer, Moderna, Johnson & Johnson, AstraZeneca, and Novavax are all involved in the development of treatments and vaccines for Covid 19. Other companies such as Gilead Sciences, Merck, and Sanofi are also involved in the development of treatments and vaccines for other infectious diseases. Show Less Read more